CMS: 49 States (+ DC) Reduced Avoidable Hospital Readmissions

According to a new study from the Centers for Medicare & Medicaid Services (CMS), 49 states and the District of Columbia have seen avoidable hospital readmissions decline since 2010.

Hospital readmissions typically occur within 30 days of a patient’s discharge and have been estimated to cost $17 billion annually in Medicare expenditures. Aside from the financial burden, avoidable readmissions can also be a sign of less than stellar care patients receive when first admitted to the hospital.

To address these concerns, the Affordable Care Act created the Hospital Readmission Reduction Program which adjusts payments for hospitals with higher than expected 30-day readmission rates. Data from the program indicates:

  • All states but one (Vermont) have seen Medicare 30-day readmission rates fall.
  • In 43 states, readmission rates fell by more than 5%.
  • In 11 states, readmission rates fell by more than 10%.

Read the complete details on the data and more information.

You may also like

  • Standardized Testing: Universal Risk Stratification System Needed for Thyroid Nodules

    With thyroid cancer patients often getting different — and sometimes conflicting — treatment recommendations from a variety of diagnostic tools, Priyanka Majety, MD, talks to Endocrine News about why it’s time for clinicians to coalesce around a single set of standards for these cases, which could potentially eliminate unnecessary procedures. Priyanka Majety, MD, assistant professor…

  • Molecular Testing and the Future of Diagnosing Thyroid Cancer

    Endocrine Society member and medical director for Endocrinology for Veracyte, Joshua Klopper, MD, talks to Endocrine News about a new tool that may have the potential to guide thyroid cancer management decisions by predicting tumor behavior via molecular signatures. In “New Data Presented at the 2023 ATA Annual Meeting Demonstrate that Veracyte’s Afirma-Based Testing Can…

Find more in